Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 40, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-02
DOI
10.1186/s13046-021-01993-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined Replenishment of miR‐34a and let‐7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical Models
- (2020) Daniela Di Paolo et al. Small
- Autophagic flux inhibition enhances cytotoxicity of the receptor tyrosine kinase inhibitor ponatinib
- (2020) Diana Corallo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer
- (2020) Marie Wong et al. NATURE MEDICINE
- Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
- (2020) Emily Capone et al. Cancers
- The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology
- (2020) Judith Wienke et al. EUROPEAN JOURNAL OF CANCER
- Overcoming Biological Barriers in Neuroblastoma Therapy: The Vascular Targeting Approach with Liposomal Drug Nanocarriers
- (2019) Fabio Pastorino et al. Small
- Nucleolin Is a Functional Binding Protein for Salinomycin in Neuroblastoma Stem Cells
- (2019) Fengfei Wang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
- (2019) Hongwei Du et al. CANCER CELL
- Nucleolin-based targeting strategies for cancer therapy: from targeted drug delivery to cytotoxic ligands
- (2019) Sofia Romano et al. DRUG DISCOVERY TODAY
- Therapeutic applications of AS1411 aptamer, an update review
- (2019) Rezvan Yazdian-Robati et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design
- (2019) Jo Lynne Rokita et al. Cell Reports
- Nucleolin is expressed in patient-derived samples and glioblastoma cells, enabling improved intracellular drug delivery and cytotoxicity
- (2018) Joana Balça-Silva et al. EXPERIMENTAL CELL RESEARCH
- Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial
- (2018) Ruth Ladenstein et al. LANCET ONCOLOGY
- Enhancement of Tumor Homing by Chemotherapy-Loaded Nanoparticles
- (2018) Mirco Ponzoni et al. Small
- New perspectives of physiological and pathological functions of nucleolin (NCL)
- (2017) Wenyu Jia et al. LIFE SCIENCES
- Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature
- (2016) Maud-Emmanuelle Gilles et al. CANCER RESEARCH
- Neuroblastoma
- (2016) Katherine K. Matthay et al. Nature Reviews Disease Primers
- The roles of nucleolin subcellular localization in cancer
- (2015) Caroline Madeleine Berger et al. BIOCHIMIE
- Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusion
- (2015) Irene Cossu et al. BIOMATERIALS
- Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma
- (2015) Guendalina Zuccari et al. JOURNAL OF CONTROLLED RELEASE
- Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches
- (2014) Cristina Bottino et al. Frontiers in Immunology
- Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex
- (2013) J. F. Wise et al. BLOOD
- Multivalent Pseudopeptides Targeting Cell Surface Nucleoproteins Inhibit Cancer Cell Invasion through Tissue Inhibitor of Metalloproteinases 3 (TIMP-3) Release
- (2012) Damien Destouches et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer
- (2011) Vera Moura et al. BREAST CANCER RESEARCH AND TREATMENT
- Oncogenic Synergism between ErbB1, Nucleolin, and Mutant Ras
- (2011) K. Farin et al. CANCER RESEARCH
- Neuroblastoma-targeted Nanoparticles Entrapping siRNA Specifically Knockdown ALK
- (2011) Daniela Di Paolo et al. MOLECULAR THERAPY
- Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice
- (2010) Diala El Khoury et al. BMC CANCER
- Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells
- (2010) Wei Zhuo et al. JOURNAL OF PATHOLOGY
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Surface Expressed Nucleolin Is Constantly Induced in Tumor Cells to Mediate Calcium-Dependent Ligand Internalization
- (2010) Ara G. Hovanessian et al. PLoS One
- Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
- (2008) F. Pastorino et al. CLINICAL CANCER RESEARCH
- Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status
- (2008) Cynthia Winter et al. PEDIATRIC BLOOD & CANCER
- Identification of Nucleolin as New ErbB Receptors- Interacting Protein
- (2008) Ayelet Di Segni et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search